Oct 30 (Reuters) - Diagnostics firm Bio-Rad Laboratories (BIO.N), opens new tab posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical ...
It's been a good week for Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders, because the company has just released its latest quarterly results, and the shares gained 7.7% to US$285. The results were ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback